From BioPolicyWiki
Revision as of 15:32, 11 July 2008 by Jreynolds (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Region Asia
Population 90,500,000
GDP (millions USD) 144,129
National Policies
Eggs for assisted reproduction no policy
Eggs for research no policy
Inheritable genetic modification ?
Preimplantation genetic diagnosis ?
Reproductive cloning PROHIBITED
Research cloning ?
Sex selection ?
Surrogacy no policy
International Agreements
2005 UN Cloning Vote YES
2005 UNESCO Sports Doping Convention not ratified

Prohibited practices

The National Ethical Guidelines for Health Research have no enforcement mechanism, but do prohibit:

  • Providing eggs
  • Surrogacy
  • The intentional creation of human zygotes, embryos or fetuses for study, research, and experimentation or for commercial and industrial purposes
  • The sale of human zygotes


Permitted and regulated practices

Under the Guidelines, research may be conducted on a human embryo only for the purpose of improving that particular embryo’s chances of being born alive and healthy.


  1. American Society for Reproductive Medicine, "IFFS Surveillance 07," Fertility and Sterility (Vol. 87. No. 4, Suppl. 1, April 2007)
  2. "Harvard School of Public Health Global Research Ethics Map," accessed on June 5, 2008